HISTEX PD Drops New Formulation

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: HISTEX PD Drops New Formulation
Generic name: TRIPROLIDINE HYDROCHLORIDE
Manufacturer: Allegis Pharmaceuticals, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 0c693f15-5d76-3dbf-e063-6294a90af9ac
SPL ID: 2b39e554-da95-1979-e063-6394a90a887a
Version: 3
Effective date: 2025-01-08
Source export date: 2026-09-28
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:38:59

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		HISTEX PD Drops New Formulation	openfda.brand_name
generic name		TRIPROLIDINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		Allegis Pharmaceuticals, LLC	openfda.manufacturer_name
ndc	package	28595-809-30	openfda.package_ndc
ndc	product	28595-809	openfda.product_ndc
ndc11	package	28595080930	derived:openfda.package_ndc
rxcui		1926926	openfda.rxcui
spl id		2b39e554-da95-1979-e063-6394a90a887a	id
spl set id		0c693f15-5d76-3dbf-e063-6294a90af9ac	set_id
unii		YAN7R5L890	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not exceed recommended dosage. Ask a doctor before use if the child has a breathing problem such as emphysema or chronic bronchitis glaucoma Ask a doctor before use if the child is taking sedatives or tranquilizers When using this product excitability may occur, especially in children may cause drowsiness sedatives and tranquilizers may increase the drowsiness effect Stop use and ask a doctor if new symptoms occur Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.